FDA's Draft Civil Money Penalty Reduction Policy Needs Clarifications - HIMA
This article was originally published in The Gray Sheet
Executive Summary
FDA's draft policy on civil monetary penalty reductions for small entities is at odds with Sec. 303(f) of the Food Drug & Cosmetic Act because it could be used to exclude certain firms that have violated agency rules within the last five years, the Health Industry Manufacturers Association maintains.